Newsroom - Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. Get the latest in the newsroom.
News Releases - Boston Scientific
4 days ago · At Boston Scientific, unwavering commitment to patients translates into the highest levels of research, quality, and innovation. Read the latest press releases.
Boston Scientific Announces Agreement to Acquire Axonics, Inc.
Jan 8, 2024 · Boston Scientific acquisition of Axonics to expand urology portfolio with differentiated technologies to treat urinary and bowel dysfunction. Read more.
In the News - Boston Scientific
Jul 24, 2024 · Find out how Boston Scientific is challenging what’s possible to address a wide range of medical conditions. Read the latest media coverage.
Boston Scientific Announces Agreement to Acquire Relievant …
Sep 19, 2023 · Boston Scientific expects to close the transaction in the first half of 2024, subject to satisfaction of customary closing conditions. Relievant is expected to generate sales in excess of $70 million in 2023 and to deliver year-over-year growth in excess of 50% in 2024.
Boston Scientific Announces Results for Fourth Quarter and Full …
Feb 1, 2023 · Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.242 billion during the fourth quarter of 2022, growing 3.7 percent on a reported basis, 8.7 percent on an operational1 basis and...
Boston Scientific Announces Agreement to Acquire Cortex, Inc.
Nov 4, 2024 · Acquisition to complement electrophysiology portfolio with solution to advance the treatment of complex atrial fibrillation. MARLBOROUGH, Mass., Nov. 4, 2024 / PRNewswire / -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Cortex, Inc., an Ajax Health company.
Features - Boston Scientific
Oct 28, 2024 · See the latest stories and videos about Boston Scientific patients, life-changing products and values-driven corporate culture.
Boston Scientific Announces Results for First Quarter 2024
Apr 24, 2024 · Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.856 billion during the first quarter of 2024, growing 13.8 percent on a reported basis, 15.0 percent on an operational1 basis...
Boston Scientific Announces Results for Fourth Quarter and Full …
MARLBOROUGH, Mass., Jan. 31, 2024 / PRNewswire / -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.725 billion during the fourth quarter of 2023, growing 14.9 percent on a reported basis, 14.5 percent on an operational 1 basis and 13.6 percent on an organic 2 basis, all compared to the prior year period.